Jonas Kingo: Factor XI at the Crossroads of Hormonal Regulation and Thrombosis at ISTH 2026
Jonas Kingo, CEO at Aniara Holding, shared a post on LinkedIn:
“A new finding published in Blood (April 2026) adds an unexpected dimension to the FXI story — directly relevant to one of ISTH 2026‘s hottest topics.
Researchers discovered that estrogen upregulates lactoferrin — an iron-binding glycoprotein traditionally associated with innate immunity — which in turn potentiates FXIa activity.
This mechanism may help explain why elevated estrogen levels correlate with elevated VTE risk in pregnancy, oral contraceptive use, and postmenopausal hormone therapy.
The significance: it reframes our understanding of hormonal regulation of coagulation and introduces FXI as a potential therapeutic target for thrombosis prevention in hormonal contexts — without necessarily impairing normal hemostasis.
This connects directly to the broader FXI inhibitor story dominating Phase 3 trials right now.
Current evidence suggests FXI is mostly dispensable for hemostasis but essential for thrombosis — and the lactoferrin link suggests its regulation is more complex and biologically integrated than previously understood.
Expect this to generate significant discussion in Paris.”
Stay updated with Hemostasis Today.
-
Nov 9, 2026, 10:32Natalie Arnold: The Lp(a) Puzzle – Why Lower Levels May Not Tell the Whole Story
-
Nov 9, 2026, 10:22ISBT Opens Applications for the I TRY IT Programme 2027
-
Nov 9, 2026, 10:08Ibrahim Mansoor: Rare Tests, Common Diseases – Rethinking Autoimmune Diagnostics
-
Nov 9, 2026, 09:29Veronica Sanchez: A Framework for Woman’s Health
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services